IP Library Granted Patent US 10,590,406
Granted Patent B2
US 10,590,406 · App. 14/961,146 · Granted Mar 17, 2020

Recombinant microorganisms exhibiting increased flux through a fermentation pathway

Inventors: Michael Koepke (Skokie, IL); Alexander Paul Mueller (Skokie, IL); Loan Phuong Tran (Skokie, IL)
Assignee: LANZATECH NEW ZEALAND LIMITED
C12N9/88C12N9/0008C12N9/1022C12N15/52C12P7/18C12Y102/07001C12Y202/01006C12Y401/01005Y02E50/17
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,590,406
App. No.
14/961,146
Granted
Mar 17, 2020
Kind
B2
Abstract

The invention provides a recombinant, carboxydotrophic Clostridium bacterium that expresses one or more of pyruvate:ferredoxin oxidoreductase (EC 1.2.7.1), acetolactate synthase (EC 2.2.1.6), and acetolactate decarboxylase (EC 4.1.1.5). The invention further provides a method of producing a fermentation product by fermenting the recombinant bacterium in the presence of a gaseous substrate comprising CO to produce one or more of ethanol, butanol, isopropanol, isobutanol, higher alcohols, butanediol, 2,3-butanediol, succinate, isoprenoids, fatty acids, biopolymers, and mixtures thereof.

Claims (16)

1. A recombinant bacterium comprising a pyruvate:ferredoxin oxidoreductase (EC 1.2.7.1), an acetolactate synthase (EC 2.2.1.6), and an acetolactate decarboxylase (EC 4.1.1.5), wherein each enzyme is an overexpressed endogenous enzyme or an exogenous enzyme, wherein the bacterium is derived from Clostridium autoethanogenum, Clostridium ljungdahlii , or Clostridium ragsdalei , and wherein the bacterium produces 2,3-butanediol and acetate.

2. The bacterium of claim 1 , wherein the pyruvate:ferredoxin is an overexpressed endogenous pyruvate:ferredoxin oxidoreductase.

3. The bacterium of claim 1 , wherein the pyruvate:ferredoxin oxidoreductase is Desulfovibrio africanus pyruvate:ferredoxin oxidoreductase.

4. The bacterium of claim 1 , wherein the acetolactate synthase is an overexpressed endogenous IlvB acetolactate synthase, an overexpressed endogenous IlvN acetolactate synthase, or an overexpressed endogenous AlsS acetolactate synthase.

5. The bacterium of claim 1 , wherein the acetolactate synthase is a feedback-insensitive IlvN acetolactate synthase.

6. The bacterium of claim 1 , wherein the acetolactate synthase is an exogenous Bacillus subtilis acetolactate synthase.

7. The bacterium of claim 1 , wherein the acetolactate decarboxylase is an overexpressed endogenous AlsD acetolactate decarboxylase or an overexpressed endogenous BudA acetolactate decarboxylase.

8. The bacterium of claim 1 , wherein the acetolactate decarboxylase is an exogenous Aeromonas hydrophila acetolactate decarboxylase.

9. The bacterium of claim 1 , wherein the acetolactate decarboxylase is an exogenous Leuconostoc lactis acetolactate decarboxylase.

10. The bacterium of claim 1 , wherein the bacterium is derived from Clostridium autoethanogenum.

11. The bacterium of claim 1 , wherein the bacterium is derived from Clostridium autoethanogenum deposited under DSMZ Accession No. DSM23693.

12. The bacterium of claim 1 , wherein the bacterium does not comprise an overexpressed endogenous or an exogenous 2,3-butanediol dehydrogenase (EC 1.1.1.4) enzyme.

13. The bacterium of claim 1 , wherein the bacterium produces higher amounts of 2,3-butanediol than a bacterium that does not comprise the overexpressed endogenous or the exogenous pyruvate:ferredoxin oxidoreductase, acetolactate synthase, and acetolactate decarboxylase.

14. The bacterium of claim 1 , wherein the bacterium produces 2,3-butanediol at a rate greater than 57 mmol/L/day.

15. The bacterium of claim 1 , wherein the bacterium produces 2,3-butanediol at a rate greater than 122 mmol/L/day.

16. A method of producing 2,3-butanediol, comprising fermenting the bacterium of claim 1 in the presence of a gaseous substrate comprising CO to produce 2,3-butanediol.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE THE PATENT NUMBE 9,5348,20 PREVIOUSLY RECORDED AT REEL: 059911 FRAME: 0400. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 4, 2022
From: LANZATECH NEW ZEALAND LIMITED
To: LANZATECH NZ INC.
Reel/Frame 061084/0646 →
CORRECTIVE ASSIGNMENT TO CORRECT THE U.S. PATENT NUMBER 8,979,228 PREVIOUSLY RECORDED AT REEL: 059911 FRAME: 0400. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 3, 2022
From: LANZATECH NEW ZEALAND LIMITED
To: LANZATECH NZ, INC.
Reel/Frame 061058/0076 →
RELEASE OF SECURITY INTEREST Recorded May 9, 2022
From: VENTURE LENDING & LEASING VII, INC.; VENTURE LENDING & LEASING VIII, INC.
To: LANZATECH NEW ZEALAND LIMITED; LANZATECH, INC.; LANZATECH FREEDOM PINES BIOREFINERY LLC; LANZATECH HONG KONG LIMITED; LANZATECH PRIVATE LIMITED; LANZATECH UK LIMITED
Reel/Frame 059910/0789 →
CHANGE OF NAME Recorded May 9, 2022
From: LANZATECH NEW ZEALAND LIMITED
To: LANZATECH NZ, INC.
Reel/Frame 059911/0400 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2016
From: KOEPKE, MICHAEL; MUELLER, ALEXANDER PAUL; TRAN, LOAN PHUONG
To: LANZATECH NEW ZEALAND LIMITED
Reel/Frame 037720/0892 →
Cited By (7)
US 12,234,492 US 12,241,105 US 12,280,331 US 12,281,344 US 12,291,734 US 12,359,224 US 12,371,727